Immunocore Holdings EPS Diluted (Quarterly) Analysis

Immunocore Holdings PLC (IMCR)

32.12 -0.30 (-0.93%) USD | NASDAQ | Nov 21, 16:00

32.06 -0.06 (-0.19%) After-Hours: 20:00

EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2019. Upgrade now.

Date	Value
September 30, 2024	0.17
June 30, 2024	-0.23
March 31, 2024	-0.49
December 31, 2023	-0.40
September 30, 2023	0.02
June 30, 2023	-0.35
March 31, 2023	-0.40
December 31, 2022	-0.6535
September 30, 2022	0.134
June 30, 2022	-0.1698

Date	Value
March 31, 2022	-0.486
December 31, 2021	-1.212
September 30, 2021	-0.9265
June 30, 2021	-1.038
March 31, 2021	-1.045
December 31, 2020	-0.9424
September 30, 2020	-0.7834
June 30, 2020	-0.0008
March 31, 2020	-0.0008
December 31, 2019	-0.0015

Earnings per Share Definition

Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.

Read full definition.

EPS Diluted (Quarterly) Range, Past 5 Years

-1.212

Minimum

Dec 2021

0.17

Maximum

Sep 2024

-0.4403

Average

-0.40

Median

Mar 2023

EPS Diluted (Quarterly) Benchmarks

Adaptimmune Therapeutics PLC	-0.06
Biodexa Pharmaceuticals PLC	--
Verona Pharma PLC	-0.56
NuCana PLC	-3.785
Autolus Therapeutics PLC	-0.31

EPS Diluted (Quarterly) Related Metrics

Net Income (Quarterly)	8.736M
Revenue (Quarterly)	80.25M
Total Expenses (Quarterly)	88.75M
Enterprise Value	1.159B
Gross Profit Margin (Quarterly)	99.44%
Profit Margin (Quarterly)	10.89%
Earnings Yield	-2.96%
Normalized Earnings Yield	-2.395